key: cord-0708177-235jhvb7
authors: Qiu, Qin; Huang, Yuge; Liu, Xiaohua; Huang, Fangfang; Li, Xiaoling; Cui, Liao; Luo, Hui; Luo, Lianxiang
title: Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
date: 2020-11-09
journal: Front Pharmacol
DOI: 10.3389/fphar.2020.570893
sha: eaa808c46f48c41b3ce6b012395d844765589a77
doc_id: 708177
cord_uid: 235jhvb7

The Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has been rapidly spreading globally and has caused worldwide social and economic disruption. Currently, no specific antiviral drugs or clinically effective vaccines are available to prevent and treat COVID-19. Traditional Chinese medicine (TCM) can facilitate syndrome differentiation and treatment according to the clinical manifestations of patients and has demonstrated effectiveness in epidemic prevention and control. In China, TCM intervention has helped to control the epidemic; however, TCM has not been fully recognized worldwide. In this review, we summarize the epidemiology and etiological characteristics of severe acute respiratory syndrome coronavirus 2 and the prevention and treatment measures of COVID-19. Additionally, we describe the application of TCM in the treatment of COVID-19 and the identification of small molecules of TCM that demonstrate anti-coronavirus activity. We also analyze the current problems associated with the recognition of TCM. We hope that, through the contribution of TCM, combined with modern technological research and the support of our international counterparts, COVID-19 can be effectively controlled and treated.

Understanding the epidemiology of this virus is a key element to develop strategies for preventing . Based on the findings of phylogenetic analysis, SARS-CoV-2 may have originated from bats or bat droppings associated with pollutants in the market or surrounding areas (Wu F. et al., 2020) . SARS-CoV-2 has three types of hosts (natural, intermediate, and final) that can be transmitted between human hosts via respiratory droplets and contact routes . Moreover, the existing evidence of SARS-CoV-2 infecting intestinal epithelial cells reminds us to focus on the possibility of fecal-oral transmission (Lamers et al., 2020) . Both asymptomatic and symptomatic patients are communicators; however, in the case of symptomatic patients, an increased viral load was observed (Kim et al., 2020) . Studies have shown that adults are more susceptible to infection than children, especially the elderly with basic diseases such as hypertension and diabetes, among whom 80.9% have mild to moderate disease, and the mortality rate of confirmed cases is about 2.3% (Chang et al., 2020; Wu and McGoogan, 2020) .

SARS-CoV-2 is a positive-sense, single-stranded RNA virus with a genome of 29.9 kb and a diameter ranging from 80 to 160 nm, and is a novel beta-coronavirus belonging to the Sarbecovirus subgenus of the Coronaviridae family . Its structure comprises a helical nucleocapsid formed by the binding of nucleic acid to the nucleocapsid (N) protein and a lipid envelope studded with structural proteins, including the membrane (M) glycoprotein, envelope (E) protein, and spike (S) glycoprotein (Boopathi et al., 2020) . The pathogenic mechanism of coronavirus includes four steps: attachment and entry, replication and transcription, assembly and release (Fehr and Perlman, 2015) . SARS-CoV-2 binds to the receptor angiotensin converting enzyme 2 (ACE2) with the help of S protein to enter cells and releases RNA that translates two polyproteins and structural proteins; thereafter, the viral genome begins to replicate . Genomic RNA and nucleocapsid proteins combine to form nucleocapsids, and then the vesicles containing the virus particles fuse with the plasma membrane to release the virus (Figure 1 ) (Knoops et al., 2008; Fehr and Perlman, 2015) . SARS-CoV-2 S proteins recognize ACE2 for entry and the serine protease TMPRSS2 for S protein priming (Hoffmann et al., 2020) . Nevertheless, more studies have focused on nonstructural proteins such as the papain-like protease (PLpro), the 3C-like protease (3CLpro) and the RNA-dependent RNA polymerase (RdRp), which are critical for viral replication . These key proteins could be potential targets for diagnostic or therapeutic application.

After infecting the host, the SARS-CoV-2 stimulates humoral and cellular immunity, causing cytokine storms, which trigger a violent attack by the body's immune system . ACE2 has been identified as the functional host receptor for SARS-CoV-2 and is widely expressed in various human organs, including the oral and nasal mucosa, nasopharynx, lung, stomach, small intestine, skin, spleen, liver, kidney, and brain ( Figure 2 ) Wang Q. et al., 2020) . Among them, ACE2 immunostaining is the most abundant in alveolar epithelial cells; thus, the lung is a target organ that is most easily affected (Hamming et al., 2004) . Autopsy reports from China and the United States both revealed diffuse alveolar injury and chronic inflammatory edema of the bronchial mucosa, confirming the occurrence of ARDS in COVID-19 patients whose main clinical manifestations are fever, cough and progressive dyspnea (Barton et al., 2020; Tian et al., 2020) . Histological analysis of pulmonary vessels in patients with COVID-19 showed extensive thrombosis with microvascular lesions, with the amount of new vessel growth 2.7 times higher than that in patients with influenza (Ackermann et al., 2020) . ACE2 is highly expressed not only in lung cells but also throughout the gastrointestinal tract (Bourgonje et al., 2020) . Some patients experience gastrointestinal symptoms, including vomiting, abdominal pain and diarrhea (Cheung et al., 2020; Cholankeril et al., 2020) , abdominal pain and diarrhea; imaging findings have suggested intestinal abnormalities (Bhayana et al., 2020) . A case report revealed that SARS-CoV-2 enterocolitis continues to expel the virus for approximately two weeks after recovering from diarrhea (Hosoda et al., 2020) , while studies from China have also found viral nucleocapsid protein in gastric, duodenal, and rectum glandular epithelial cells . However, more evidence is needed to determine whether the virus has the possibility of fecal-oral transmission . Several reports have indicated that the elevation of transaminase in patients suggests liver damage should be given attention (Feng et al., 2020; . SARS-CoV-2 infection is also associated with various diseases of the cardiovascular system, including myocarditis, cardiomyopathy and excessive vasoconstriction (Craver et al., 2020; Moderato et al., 2020) . Some critically ill patients have abnormal hemagglutination with high D-dimer levels and elevated fibrinogen, which may cause vascular embolism, resulting in pulmonary embolism and stroke (Hess et al., 2020; Lax et al., 2020) . If the virus appears in cutaneous blood vessels in patients with COVID-19, they may cause corresponding pathologic changes (Gianotti et al., 2020; Llamas-Velasco et al., 2020; Torres and Puig, 2020) . The presence of the virus in the nerve and capillary endothelial cells in the frontal lobe tissue of an infected patient indicates that the virus can penetrate the blood-brain barrier to attack the central nervous system directly (Paniz-Mondolfi et al., 2020; Reichard et al., 2020) . Therefore, some patients have nervous system manifestations such as anosmia, dysgeusia, ataxia, and an altered mental status (Baig, 2020) . Additionally, research data have shown that the mortality of patients with COVID-19 is related to the prevalence of kidney disease on admission , and virus particles have been found in renal tubular epithelial cells under ultrastructure, providing evidence of direct infection of the kidney by SARS-CoV-2 (Farkash et al., 2020) . In addition to the direct virulence of SARS-CoV-2, factors contributing to acute kidney injury include systemic hypoxia, abnormal coagulation, and possible drug or hyperventilation-relevant rhabdomyolysis . Notably, Xixi Liu et al. found that ACE2expressing cells exist in almost all testicular cell types, and sertoli cells have the highest expression level and positive cell ratio . Zhengpin Wang et al. also confirmed that the human testis is a potential target for SARS-CoV-2 from the level of single-cell transcription . Thus, SARS-CoV-2 causes damage to multiple organs of the host through various factors, especially hypertension, the elderly, obesity, male individuals with severe cardiovascular disease and those with blood group A (Menter et al., 2020) . Therefore, the integration of multiple disciplines to carry out comprehensive diagnoses and treatment for patients with COVID-19 is warranted.

Although SARS-CoV-2 is widespread and causes multiple organ damage, no specific antiviral drugs or vaccines are currently available. Prevention and supportive care are the main treatment strategies for COVID-19 (Jin et al., 2020) . As one of the first affected countries, the epidemic in China has been well controlled, proving the importance of non-drug intervention (NPI), including the isolation of ill persons, contact tracing, quarantine of exposed persons, travel restrictions, school and workplace closures, cancellation of mass gatherings, and hand washing, among others . At present, there are mainly the following categories of drugs used to treat COVID-19, including antiviral drugs (e.g., remdesivir), antibodies (e.g., convalescent plasma), anti-inflammatory drugs (e.g., dexamethasone), and targeted immunomodulatory therapy (e.g., tocilizumab) (Gautret et al., 2020) . Most antiviral drugs currently used to treat COVID-19 were initially developed for influenza, Ebola, or SARS/MERS. Convalescent plasma might be a potential therapy for critically ill patients infected with SARS-CoV-2 . As a monoclonal antibody against inflammatory cytokines, tocilizumab has emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms (Luo P. et al., 2020) . In addition, for the use of corticosteroids in the treatment of COVID-19, a study has been found that corticosteroids can reduce pulmonary immune inflammatory responses, but delay viral clearance, and systemic use is not recommended in patients with SARS-CoV-2 infection (Russell et al., 2020) . However, another controlled, open-label trial found that dexamethasone use resulted in lower 28-days mortality in patients randomized to invasive mechanical ventilation or oxygen alone, compared with no benefit in patients with shorter duration of symptoms and no need for supplemental oxygen (Horby et al., 2020) . The development of vaccines is the key to halting the spread of the virus. Thus, clinical trials have been carried out in many countries, among which the fastest progress concerns adenovirus vector vaccines, mRNA vaccines, DNA vaccines and inactivated vaccines, which have entered the clinical stage (Amanat and Krammer, 2020) .

According to the History of Chinese Epidemics published by the Chinese Academy of Traditional Chinese Medicine, 321 epidemics have occurred in China in the past 2000 years since the Western Han Dynasty and have been resisted effectively by TCM (Medicine, 2003.06) . The efficacy of TCM has been confirmed in the process of fighting severe acute respiratory syndrome (SARS) in 2003 (Chen and Nakamura, 2004; Zhang et al., 2004) . TCM has achieved phased victories in China. According to statistics released by the China Administration of Traditional Chinese Medicine, 92.58% of the confirmed COVID-19 patients nationwide were treated with TCM, and the effective rate of TCM participation reached 95.10% up to March 3 (Medicine NAoTC, 2020h). TCM has therapeutic effects on all clinical stages of COVID-19 (Xiang et al., 2020) . For mild and ordinary stages, TCM can relieve clinical symptoms (fever, shortness of breath, cough, diarrhea), shorten the course of the disease, improve the cure rate, and prevent the disease from becoming severe. For severe and critical cases, combined with supportive therapy such as oxygen therapy and fluid replacement in modern medicine, TCM can enhance pulmonary ventilation function and inhibit lung injury and an excessive immune response. In the rehabilitation stage, patients usually still have deficiencies in qi and yin. Thus, taking TCM compound decoctions with the effects of supplementing qi, nourishing yin and strengthening the spleen and tonifying the lung can help to restore physical strength, promote the absorption of pulmonary inflammation and reduce pulmonary interstitial fibrosis (Ang et al., 2020a; Liu, 2020) . The successful experience of fighting COVID-19 has shown that TCM has a unique advantage in infectious diseases.

The development of new agents against COVID-19 is not realistic to pass safety and toxicity tests in a short period and is both time-Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 570893 consuming and costly. Therefore, active compounds targeting viruses or host targets in existing Chinese herbal medicines were screened by many scientists. Currently, various natural compounds have been found to potentially possess anti-SARS-CoV-2 activity. In this review, we focus on six compounds: hesperetin, baicalin, curcumin, glycyrrhizic acid, luteolin, and rutin. The pharmacological action and targeting targets of these six compounds are shown in Table 1 .

Hesperetin, a flavonoid from the pericarp of citrus, has the biological characteristics of antioxidation and antiinflammation (Parhiz et al., 2015) . Hesperetin inhibited the cleavage activity of SARS-CoV 3C-like protease (3CLpro) in a dose-dependent manner, in which the IC 50 was 8.3 μmol/l in the Vero cell lysis assay (Lin et al., 2005) . Using computer virtual screening, hesperetin showed good binding affinity for 3CLpro (Wu et al., 2020a) . Additionally, it binds well to COVID-19 Main protease (Mpro) (Adem et al., 2020) and may destroy the interaction between the receptor-binding domain (RBD) and ACE2 by binding to RBD in SARS-CoV-2 S protein (Wu et al., 2020a) .

Baicalin is a flavonoid compound extracted and isolated from Scutellaria baicalensis Georgi, which has multiple biological activities, including anti-inflammatory, antioxidant, and neuroprotective effects (Hwang et al., 2005; Shi et al., 2017; Guo et al., 2019) . Scientists have proven that baicalin has anti-SARS-CoV virus activity in vitro using the fetal rhesus kidney-4 (fRhK-4) cell line, in which the EC 50 was 12.5 μg/ml at 48 h and the Vero-E6 cell line in which the EC 50 was 100 μg/ml at 48 h; in the plaque reduction assay, using Vero cell line, the EC 50 of baicalin was 11 μg/ml . The results of molecular docking showed that baicalin has a strong binding affinity to the ACE2 receptor (Chen and Du, 2020b) .

Curcumin, a known phenolic compound extracted from the rhizome of turmeric, showed broad pharmacological effects, including antioxidant, anti-inflammatory, anti-virus and anticancer activities (Anand et al., 2008; Aggarwal and Sung, 2009; Moghadamtousi et al., 2014) . Curcumin has activity against SARS-CoV replication with concentrations between 3.3 and 10 μmol/l, and inhibitory effects on 3CLpro were observed with IC 50 values of 40 μmol/l (Wen et al., 2007) . The release of IL-1, IL-6 and TNF-α in the treatment of patients with a cytokine storm was blocked by curcumin (Sordillo and Helson, 2015) . The results of molecular docking using virtual screening showed that curcumin possess good affinity to PLpro, the RBD of spike glycoprotein (RBD-S), and the ACE2 receptor at the protease domain (PD-ACE2) (Goswami et al., 2020; Utomo and Meiyanto, 2020) .

Glycyrrhizic, also called glycyrrhizin, is one of the most important active ingredients in Glycyrrhiza glabra L., which has many (Moghadamtousi et al., 2014; Goswami et al., 2020) Glycyrrhizic acid Antiviral, antioxidant, immunomodulatory, cell membrane stabilization ACE2 (Pang et al., 2016; Chen and Du, 2020b) Luteolin Antioxidation, anti-inflammation, anti-tumor 3CLpro, RdRp, PLpro, Spro (Xiong et al., 2017; Yu et al., 2020) Rutin Anti-inflammation, anti-virus, anti-oxidation, neuroprotective effects Mpro (Chua, 2013; Huynh et al., 2020) Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 570893 5 biological activities such as antiviral, antioxidant, immunomodulatory and cell membrane stabilization (Yong and Haji, 2010; Akman et al., 2015; Pang et al., 2016) . In addition to inhibition of SARS-CoV replication, glycyrrhizin inhibits the adsorption and penetration of the virus and is less effective during the adsorption period (EC 50 , 600 mg/l) and after the virus adsorption period (EC 50 , 2,400 mg/l) and most effective both during and after the adsorption period (Cinatl et al., 2003) . Chen et al. used systems biology tools to identify that a novel combination of vitamin C, curcumin and glycyrrhizic acid (VCG Plus) may regulate the immune response against SARS-CoV-2 infections by acting on NOD-like and Toll-like signaling pathways and inhibit excessive inflammatory responses to prevent the onset of a cytokine storm by inhibiting PI3K/ AKT, NF-κB and MAPK signaling pathways . The activity of ACE2 in cells may be regulated by the binding of glycyrrhizin to ACE2, 3CLpro, Spike, PLpro, and RdRp Chen and Du, 2020b) .

As a natural flavonoid, luteolin not only has multiple effects such as antioxidation and anti-inflammation but also inhibits the proliferation of tumor cells (Xiong et al., 2017; Yu et al., 2019) . Luteolin dose-dependently inhibited the cleavage activity of SARS coronavirus, and the EC 50 value was 10.6 μmol/l (Yi et al., 2004 ). An in vitro study showed that luteolin could inhibit SARS-CoV 3CLPro, with an IC 50 of 20.2 μmol/l (Ryu et al., 2010) . Through molecular docking, luteolin showed strong interactions with the targets of SARS-CoV-2, including 3CLpro, RdRp, PLpro, and Spro .

Rutin, a type of flavonoid, is an effective component of Lianhua Qingwen, which has many effects, such as anti-inflammation, anti-virus, anti-oxidation, and neuroprotective effects (Javed et al., 2012; Chua, 2013) . Various RNA viruses, including influenza A virus (IAV) and enterovirus A71 (EV-A71), are inhibited by rutin (Savov et al., 2006; Lin et al., 2012) . Molecular dynamics simulation suggests that rutin can bind stably to the Mpro' pocket of SARS-CoV-2 and block the binding of substrate in space (Huynh et al., 2020) .

Through the enumeration of several compounds, it was found that flavonoids (e.g., hesperetin, baicalin and luteolin) have shown outstanding in fighting against the COVID-19. Flavonoids, a class of secondary metabolites produced by plants in the process of long-term natural selection, have a variety of pharmacological activities including antiviral, antiinflammatory, cardiovascular and cerebrovascular disease prevention, antioxidation and anti-tumor, etc (Panche et al., 2016; Brodowska, 2017) . Its unique and common chemical structure, i.e., C6-C3-C6 consisting of 2 aromatic rings (A and B) linked by a three-carbon chain (Kumar and Pandey, 2013) . The hydroxylation pattern of the B ring of certain flavonoids enhanced the inhibitory effect of mast cells and macrophages on cytokine secretion (Ginwala et al., 2019) . Flavonoids exerts express their anti-inflammatory activity by inhibiting the synthesis and activity of pro-inflammatory mediators (e.g., eicosanoids and cytokines), inhibiting the activation of transcription factors (e.g., NF-kappaB and activating protein-1) and modulation of proinflammatory gene expression (Kim et al., 2004; Serafini et al., 2010) . High affinity binding between flavonoids and S protein, helicase, and protease sites on ACE2 resulting in conformational change, thereby inhibiting viral entry of SRAS-CoV-2. In addition, saikosaponins have great potential in the treatment of COVID-19 through immunomodulatory, anti-inflammatory and antiviral activities. On the one hand, saikossaponins exhibit anti-inflammatory effect by dosedependently inhibiting the production of several inflammatory mediators which are responsible for the cytokine storm of severe COVID-19 patients, and immunomodulatory effect by inhibiting the proliferation of activated T lymphocytes (Bahbah et al., 2020) . On the other hand, it can also directly bind to ACE2 to play the role of anti-SARS-CoV-2 (Yan Y.-M. et al., 2020) . In short, most of the naturally active compounds reviewed by us show antiviral and anti-inflammatory effects and may possess anti-SARS-CoV-2 effects according to the results of computer simulation and in vitro experiments, but further in vivo and clinical trials are needed to verify.

In addition to compounds, many TCM herbal formulas are also widely used in the treatment of COVID-19. The formula therapy of TCM diagnosis and treatment has the advantages of multitarget and multi-link treatment. TCM herbal formulas such as Qingfei Paidu decoction, Huashi Baidu recipe, Lianhua Qingwen capsule and Xuebijing injection have demonstrated curative effects on COVID-19 ( Table 2 ) (Medicine NAoTC, 2020h). Among them, the clinical stages are mainly based on the Guideline on Diagnosis and Treatment of Coronavirus disease 2019 in China (Medicine NAoTC, 2020f).

Jin Hua Qing Gan granule (JHG) have antiviral and immune regulation effects (Jimilihan, 2020) . However, according to the current study, JHG plays an anti-COVID-19 effect mainly through modulating cytokine storm associated with COVID-19 mortality and acting directly on the virus itself (Ruan et al., 2020) . The arachidonic acid (AA) metabolic pathway is mainly used to synthesize inflammatory cytokines; thus, inhibiting the AA metabolic pathway is beneficial to reduce the "cytokine storm." Ren Y et al. showed that JHG might be anti-COVID-19 by treating the cytokine storm based on the AA metabolic pathway (Ren et al., 2020) . A recent retrospective analysis test showed JHG can effectively shorten the duration of nucleic acid detection and promote the absorption of pneumonia inflammatory exudate without obvious adverse reactions in patients with COVID-19 . A systematic analysis of multiple prospective randomized controlled trials provide evidence to determine that JHG is an efficacy and safety treatment for COVID-19 . JHQ is mainly used for COVID-19 patients with fever, cough, fatigue, headache and runny nose (Zhuang et al., 2020) . At present, no adverse reactions reported. According to the recommended dosing methods of National Administration of Traditional Chinese Medicine, JHG is dissolved in boiling water and a bag or two 3 times a day for 5 or 7 days (Medicine NAoTC, 2020c).

Lian Hua Qing Wen capsule (Lianhua Qingwen) is developed from the two classical formulas Fang Ma Xing Shi Gan Tang and Yinqiao Powder. In addition to improving the clinical symptoms of COVID-19 patients through anti-inflammation, Lianhua Qingwen can also act directly on the virus itself. In vitro studies have shown that Lianhua Qingwen can significantly inhibit the replication of SARS-CoV-2 in Vero E6 cells and significantly reduce the production of proinflammatory cytokines such as TNF-α, IL-6, CCL-2/MCP-1 and CXCL-10/ IP-10. On the other hand, it affects the morphology of the virus at the mRNA level (Runfeng et al., 2020) . The efficacy of Lianhua Qingwen in the treatment of H1N1 infection is similar to that of oseltamivir in terms of disease duration and virus shedding (Duan et al., 2011) . A prospective, multicenter, open-label, randomized controlled trial including 284 confirmed COVID-19 (142 each in the treatment and control groups) displayed that add-on Lianhua Qingwen led to a shorter recovery time of fever, fatigue and coughing, a higher rate of improvement in chest computed tomographic manifestations and higher clinical cure; meanwhile, no serious adverse reactions were reported . Furthermore, Lianhua Qingwen was effective in improving clinical symptoms such as fever, shortness of breath, anorexia, fatigue and cough in COVID-19 patients, reported on two retrospective cohorts Yao et al., 2020) . In summary, Lianhua Qingwen was effective in improving the fever, cough, and fatigue of COVID-19, and no serious or adverse drug reactions were reported. The recommended dose is four capsules three times a day for 14 days Medicine NAoTC, 2020c) .

The main components of Xue Bi Jing injection (XBJ) are Carthamus tinctorius L., Paeonia lactiflora Pall., Conioselinum anthriscoides "Chuanxiong," Salvia miltiorrhiza Bunge and Angelica sinensis (Oliv.) Diels, which have been widely used for sepsis with no significant adverse events (Yin and Li, 2014) . XBJ can not only anti-inflammatory but also direct action on SARS-CoV-2 in treating COVID-19. In terms of anti-inflammatory, XBJ injection reduces inflammatory reaction by down-regulating the expression of TLR4 and NF-κB, preventing lung injury caused by DDVP poisoning (He et al., 2018) . XBJ improves survival in septic shock, and its mechanism is also related to inhibition of the immune response by preventing cytokine storm attack and regulating the balance of Tregs/Th17 cells . Therefore, treatment of COVID-19 with XBJ may be related to cytokine storm treatment (Ren et al., 2020) . In terms of acting on the virus, in vitro experiments showed that XBJ could block the proliferation of SARS-CoV-2 and protect cells from SARS-CoV-2-induced cell death (Wen et al., 2020) .

Treating severe community-acquired pneumonia with XBJ can improve the pneumonia severity index, reduce the mortality, reduce the time of mechanical ventilation and shorten the hospitalization time of ICU stay . Randomized controlled clinical trials revealed that XBJ may improve lung injury in patients with severe or critical COVID-19 (Wen et al., 2020) . Another clinical research showed that, XBJ can effectively improve the inflammatory markers (such as white blood cell, lymphocyte count and C-reactive protein) and prognosis of severe COVID-19 patients (Wen et al., 2020) . XBJ is mainly applied to treat sepsis, infection-induced systemic inflammatory response syndrome, and multiple organ dysfunction syndrome (Medicine NAoTC, 2020c). Now, there was no reports of any adverse reactions to the treatment. Its usage and dosage is 100 ml XBJ plus 100 ml 0.9% sodium chloride injection for intravenous drip every 12 h for 7 days (Ma et al., 2020b; Medicine NAoTC, 2020c) .

Qing Fei Pai Du decoction (QFPDD) is made by adding and subtracting Ma Xing Shigan Tang, Wuling San, Shegan Mahuang Tang and Xiao Chaihu Tang in Zhang Zhongjing's "typhoid fever." Among them, Ma Xing Shigan decoction interferes with SARS-CoV-2 infection by regulating various complement and coagulation cascades and the thrombin system in vivo . The mechanism of QFPDD against COVID-19 may be related to the regulation of anti-viral, anti-inflammatory activity and metabolic programming. Recently, clinical observation in four provinces of China showed that the total effective rate of Qingfei Paidu decoction in the treatment of COVID-19 patients is more than 90%, in which more than 60% of the patients' symptoms and imaging manifestations improved significantly (n 214) (Medicine NAoTC, 2020g). Observation of the curative effect of 1,262 cases of COVID-19 in 66 designated units in China demonstrated that it blocks disease progression in critical patients (Medicine NAoTC, 2020e). QFPDD decoction, a only general prescription, can treat all stages (light, ordinary, severe and critical), which has the characteristics of definite curative effect, convenient use, no side effects, and low cost (Medicine NAoTC, 2020d). Recommended treatment options is one dose daily with half of the dose taken in the morning and half in the evening (40 min after meal) with warm water for 3 days, and a course of three doses. The first course of treatment should use the original prescription. If the symptoms improve but are not cured, take the second course, in which the prescription can be modified according to the actual situation. The treatment should be stopped with the symptoms disappear (National Health Commission, 2020; Medicine NAoTC, 2020d).

The theory in Traditional Chinese Medicine that "lung being connected with large intestine" is associated with the gut-lung axis. TCM alleviates and cures lung diseases by regulating the balance of the intestinal microenvironment of COVID-19 patients (Luo et al., 2020b) . Huo Xiang Zheng Qi powder has therapeutic effects on gastrointestinal diseases (Zhao et al., 2018) . The plaque reduction test explained that Liu Shen capsule (LS) Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 570893 could significantly inhibit the replication of SARS-CoV-2 in Vero E6 cells (IC 50 0.6024 μg/ml) and reduce the production of proinflammatory cytokines, a finding that may be related to the regulation of the expression of key proteins in the NF-κB/MAPK signaling pathway (Ma et al., 2020a) . In a clinical study, Tan-reqing injection was reported to have therapeutic effects on acute lung injury (ALI), reducing the levels of the serum inflammatory factors TNF-α, IL-6 and IL-8, delaying the progress of systemic inflammatory response syndrome (SIRS), slowing down the progress of SIRS and reducing the degree of respiratory distress (Yang et al., 2010) . Postresuscitation lung injury was attenuated by Shen-fu injection in vivo by inhibiting lung cell apoptosis and improving energy metabolism and antioxidant capacity (Zhang et al., 2012) . In addition, through in vivo and clinical trials confirmed that miRNA in honeysuckle decoction can be effectively absorbed through drinking, and effectively inhibits SARS-CoV-2 replication in vivo, and accelerates the negative conversion of COVID-19 patients .

COVID-19 belongs to the category of "epidemic" in TCM because of its strong infectivity and fast spread with the characteristics of "dampness, poison and epidemic", whose main site is the lung, involving the spleen and stomach (Luo et al., 2020a) . Cold-dampness and dampness-heat in the lung symptoms are shown in mild cases of COVID-19, dampness toxin and cold-dampness obstructing the lung symptoms in ordinary, epidemic toxin obstructing the lung and blazing of both qi and nutrient symptoms in severe, and internal block and external collapse symptoms in critical . In TCM theory, the properties of herbal drugs include four fundamental characters: cool, cold, warm, and heat and five fundamental tastes: pungent, sweet, bitter, sour, and salty. Among the formulas of COVID-19 issued in China, the four flavors of the drugs for COVID-19 are mainly warm, cold, and flat, the five tastes were mainly bitter, hot, and sweet, and the meridians were mainly lung, stomach, and spleen . The pungent medicines are mostly used in the early stage, which the bitter drugs are valued in the middle and severe stage, and the sweet medicines are mostly found in the recovery stage . For example, JHG granule, Huo Xiang Zheng Qi powder, Lianhua Qingwen capsule and Xuan Fei Bai Du granule are widely used in mild and ordinary patients, with Ephedra sinica Stapf, Pogostemon cablin (Blanco) Benth and Carthamus tinctorius L. and other pungent herbal drugs. XBJ injection, Shen-fu injection and Tan re qing injection are valued in severe and critical patients. It is worth pointing out that Hua Shi Bai Du recipe and QFPDD have the characteristics of mild in nature and taste, having therapeutic effects on all periods. In fact, most of these herbal drugs have the effects of resolving dampness and detoxifying. Among them, Glycyrrhiza glabra L., Scutellaria baicalensis Georgi, Ephedra sinica Stapf, Pogostemon cablin (Blanco) Benth, Carthamus tinctorius L., Prunus amygdalus Batsch and Magnolia officinalis Rehder and E.H.Wilson are used more frequently . Pogostemon cablin (Blanco) Benth and Thespesia populnea (L.) Sol. ex Corrêa are frequently used to treat medical ailments, such as removing dampness (Yang et al., 2016; Lv et al., 2018) . Lonicera japonica Thunb. and Glycyrrhiza glabra L. are popular with efficacy of clearing heat and detoxifying used in TCM (Nomura et al., 2002; Cao et al., 2012) . However, presently studies on the treatment of COVID-19 TCM herbal formulas were mostly in vivo and in vitro studies, retrospective studies and case-control trials; few rigorous randomized controlled trials (RCTs) were carried out; thus, more RCTs should be carried out.

Due to the different research methods and theoretical systems, traditional Chinese medicine and western medicine have their unique characteristics and advantages. TCM focuses on an overall approach to the analysis of illness and the patient's condition, and carries out diagnosis and treatment from integrative and holistic points of view. Different from TCM, western medicine focuses on the common law of diseases and treats it through analysis. Integrated traditional Chinese and western medicine (abbreviated as "integrated medicine") for COVID-19 has been successful in China. Respiratory support and circulatory support are important treatment methods in western medicine, while TCM has shown beneficial effects in improving clinical symptoms, immune regulation and organ protection . Clinical studies have shown that integrated medicine tends to decrease the mortality rate of SARS (Zhang et al., 2004) and is superior to western medicine in improving the 

Clinical stage Therapeutic effect References

Xue Bi Jing injection Carthamus tinctorius L., Paeonia lactiflora Pall., Conioselinum anthriscoides "Chuanxiong", Salvia miltiorrhiza Bunge, Angelica sinensis (Oliv.) Diels

Severe, critical "Dissolve stasis and detoxifying." Immune regulation Shen Fu injection Panax ginseng C.A.Mey., Aconitum carmichaeli Debeaux

Severe, critical "Restoring yang to rescue collapse and replenishing qi to prevent collapse." Reportedly has anti-inflammatory and immune regulation effects (Liu et al., 2019) Tan Re Qing injection Scutellaria baicalensis Georgi, Fel Ursi, Lonicera japonica Thunb., Corne Caprae Hirci, Forsythia suspensa (Thunb.) Vahl

Severe, critical "Clear heat and detoxifying, and resolving phlegm" according to TCM theory. Reportedly has antiviral, anti-inflammatory and immune regulation effects (Jiang et al., 2009) Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 570893 9 clinical symptoms of COVID-19 patients . Nelfinavir in combination with spilanthol to treat COVID-19 was found to enhance its ability to control viral proliferation and improve the risk of disease progression and transmission (Ohashi et al., 2020) . A systematic review and meta-analysis of the efficacy and safety of integrated medicine for COVID-19 including 11 studies from six databases revealed that the overall response rate (p 0.000), cure rate (p 0.002), severity illness rate (p 0.012), hospital stay (p 0.002) and clinical symptom improvement rate (p < 0.05) were better than those of western medicine alone . Another systematic review and meta-analysis showed that integrated medicine significantly improves the total effective rate, cough symptom disappearance rate, and sputum production symptom disappearance rate (Ang et al., 2020b) . Therefore, integrated medicine can improve the clinical efficacy and has good prospects.

Due to the limitations of P3/P4 experimental conditions, the use of computer network technology has increased in drug research and development, such as network pharmacology, artificial intelligence, and CRISPR technology, which can accelerate drug research and development, reduce research costs and save research resources.

Network pharmacology, a new discipline based on the theory of systems biology and biological system network analysis, clarifies the mechanisms of multi-component, multi-target, and multipathways. Both TCM and network pharmacology emphasize a comprehensive understanding of diseases. Kaempferol, baicalein and oroxylin A in JHG might regulate various signaling pathways (such as PTGS2, BCL2 and CASP3) by binding to ACE2, thus playing a therapeutic role in the treatment of COVID-19 (Jimilihan, 2020) . The mechanism of Lianhua Qingwen in the treatment of COVID-19 may be to improve human immunity by participating in T-cell and B-cell receptor signal transduction and natural killer cell-mediated cytotoxicity, as well as to exert antiinflammatory effects through Fc epsilon RI, ErbB, ErbB, MAPK and other signal pathways (Ye et al., 2020) . The protein interaction map screened 66 potential targets (e.g., Nsp1, Orf10, Spro, and Npro) and 69 potential drugs (e.g., chloroquine and azithromycin) of SARS-CoV-2 (Gordon et al., 2020) .

Artificial intelligence (AI) has gradually become an important factor affecting the development of the pharmaceutical industry and has been widely used in numerous medical fields, such as intelligent medical robots, voice intelligence diagnosis and treatment, medical and health management systems, and drug research and development. AI is widely used in the prevention and control, diagnosis and treatment of COVID-19. Regarding prevention and control, through establishing a scientific model of an infectious disease transmission mechanism, a significant effect of community prevention and control policies will occur when 40-60% of the group abide by the policy. Additionally, a travel restriction policy can effectively reduce the risk of disease transmission caused by an insufficient proportion of people who abide by the policy (St-Onge et al., 2020) . In terms of diagnosis, an AI model using CT images to assist in the diagnosis of COVID-19 was successfully established, with a total accuracy of 83% and that is rapid and efficient . Concerning treatment, AI is mainly used in the design and screening of small-molecule drugs. Baritinib, an effective immunosuppressant approved by the U.S. Food and Drug Administration (FDA), has been predicted to reduce the ability of novel coronavirus to infect lung cells (Richardson et al., 2020) . Glycyrrhizin significantly inhibits the replication of SARS-CoV-2 in Vero E6 cells by imitating type I interferon (EC 50 2.39 μmol/l) . Professor Li Hua's research team proved that Platycodon grandiflorum saponins D and baicalin had high affinity with PLpro, and andrographolide and its derivatives with 3CLpro and RdRp by gene sequence comparison, homologous modeling and computer virtual target screening (Wu et al., 2020b) .

Many other modern science and technologies are also used in COVID-19 in addition to network pharmacology and AI. Molecular docking techniques have been used to predict the ACE2-binding abilities of baicalin, scutellarin, hesperetin, nicotine, and glycyrrhizin, which are possible therapeutic agents for COVID-19 (Chen and Du, 2020a) . A prophylactic antiviral CRISPR in human cells (PAC-MAN) for viral inhibition has been developed that can effectively degrade RNA from SARS-CoV-2 sequences and live influenza A virus (IAV) in human lung epithelial cells (Abbott et al., 2020) . The proteome and metabolite profiles of 99 serum samples (53 control vs. 46 COVID-19) were obtained by high-resolution mass spectrometry, and the results showed that molecular changes in the serum of patients with severe COVID-19, such as macrophage dysfunction, platelet degranulation, the complement system pathway and global metabolic inhibition . Moreover, Watanabe et al. (2020) used a site-specific mass spectrometric approach to map the glycan-processing states of SARS-CoV-2 S protein.

Proteomics revealed changes in the protein levels and pathways in host cells infected with SARS-CoV-2 and demonstrated that SARS-CoV-2 replication in cells could be prevented by inhibiting compounds of these pathways (Bojkova et al., 2020) . Single-cell RNA sequencing (scRNAseq) used to analyze the peripheral immune response of patients with severe COVID-19, the results showed that peripheral immune cell phenotype was reconfigured and peripheral blood monocytes and lymphocytes did not express a large number of pro-inflammatory cytokines indicating that they were not involved in the cytokine storm (Wilk et al., 2020) . Using RNAscope technique, it was found that the expression Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 570893 levels of ACE2 and TMPRSS2 in nasal epithelial cells were significantly higher than the lower respiratory tract indicating the nasal susceptibility to SARS-CoV-2. Furthermore, the increase of CD68 + and CD163 + macrophages in inflammatory infiltrating pulmonary parenchyma cells was observed based on RNAscope technique in a rhesus macaque model of SARS-CoV-2 infection (Chandrashekar et al., 2020) . Modern science and technology have not only played important roles in fighting the COVID-19 epidemic but have also provided an objective theoretical basis for the clinical application of TCM.

TCM is not only one of the greatest treasures of ancient Chinese science but also the key to the treasure house of Chinese civilization. Different from western medicine, a very important point is that TCM upholds the theory of "treat disease before it arises." The theory emphasizes disease prevention, as well as early diagnosis and treatment to prevent aggravation of the disease. TCM has been administered early, widely and in many participants, reflecting its unique value in the prevention and control of COVID-19 epidemic. TCM can inhibit the growth of the virus in the body, relieve patients' symptoms and prevent serious development of the disease with the functions of clearing heat, removing dampness and detoxification (Medicine NAoTC, 2020e). According to Chinese news reports, TCM has been used in more than 90% of COVID-19 patients (Liu, 2020) , and the effective rate of integrated medicine is more than 92% in Beijing (Medicine NAoTC, 2020a). Because of the lack of convincing and strict experimental data, the therapeutic effect and safety of TCM have been questioned and is the main problem in the development and modernization of TCM.

Presently, most clinical studies of TCM are case reports and case-control studies, with a lack of rigorous and scientific randomized controlled trials (RCTs). Thus, the findings lack strong scientific evidence to be widely recognized. To address this problem, the TCM Clinical Evidence database (http://www. tcmevd.com/evidence/index) has been launched on April 22, 2020. Additionally, attention should be focused on standardized clinical studies of TCM, and communication between evidence-based medicine fields domestically and abroad should be strengthened. Moreover, the mysterious veil of TCM can be lifted, and the modern medical systems can be enriched and improved with the help of modern science and technology. TCM has many ingredients, unclear effective activity and complex mechanisms; thus, it is difficult to effectively guarantee its safety. Fortunately, these drawbacks can be clarified with modern science and technology, such as network pharmacology, molecular docking technology and data mining (Ye et al., 2020) . The process and dynamic changes of TCM in vivo can be confirmed through pharmacokinetic and metabonomic studies. AI has contributed to the improvement of the service system of modern traditional Chinese medicine . Importantly, the lack of objective evaluation criteria for the diagnosis and treatment of TCM is a serious problem. TCM diagnosis refers to collecting information on clinical symptoms and signs using four diagnostic processes-looking, listening and smelling, asking and cutting-which are very subjective and closely related to personal experience. Thus, the information in the process of diagnosis should be standardized and digitized, and a scientific diagnostic standard and a systematic evaluation system should be established. TCM is gradually being adopted worldwide because of its unique advantages and efforts by the Chinese, and is expected to make positive contributions to the health of all people globally.

With the outbreak of COVID-19 epidemic, great efforts are being made to understand the pathogenesis and clinical characteristics of the disease to identify effective drugs and vaccines. However, no specific antiviral drugs and vaccines are available currently. Symptomatic and supportive therapies are the main treatment approaches, including general therapeutic measures, antiviral therapy and respiratory support. The history of TCM fighting against epidemics has spanned thousands of years. In China, TCM has been widely and deeply involved in the diagnosis and treatment of COVID-19 and has played a positive role in this war. Treatment using integrated traditional Chinese and western medicines has achieved success, and modern science and technology have made significant contributions. COVID-19 treatment results have shown that TCM is effective in relieving symptoms, improving the cure rate, reducing mortality, and promoting the rehabilitation of convalescent people, without world recognition. Presently, TCM diagnosis and treatment still lack objective evaluation criteria, its efficacy lacks strong scientific evidence, and its mechanisms of action are unknown. To realize the modernization of TCM, we should focus on evidence-based medicine, combined with science technology, and establish standards of diagnosis and treatment. We hope that, through the contribution of TCM, combined with modern technological research and the support of our international counterparts, COVID-19 can be effectively controlled and treated.

LL conceived and designed the review; QQ, FH, XHL, XLL, and LL wrote the manuscript; LL, YH, HL, and LC reviewed the paper and provided comments, and all of the authors reviewed the manuscript. 

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar. 2020.570893/full#supplementary-material

Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19

Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

The neuroprotective effect of glycyrrhizic acid on an experimental model of focal cerebral ischemia in rats

SARS-CoV-2 vaccines: status report

Biological activities of curcumin and its analogues (Congeners) made by man and mother nature

Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines

Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of randomized controlled trials

Purposing saikosaponins for the treatment of COVID-19

Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement

COVID-19 autopsies

Abdominal imaging findings in COVID-19: preliminary observations

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease

Natural flavonoids: classification, potential role, and application of flavonoid analogues

Global detection and analysis of volatile components from sun-dried and sulfur-fumigated herbal medicine by comprehensive two-dimensional gas chromatography/ time-of-flight mass spectrometry

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

Potential natural compounds for preventing 2019-nCoV infection

Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection

Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19)

A novel combination of vitamin C, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: a perspective from system biology analysis

Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of proand anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS

Kidney disease is associated with in-hospital death of patients with COVID-19

Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis

6 effective TCM recipes for COVID-19

High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: early experience from California

A review on plant-based rutin extraction methods and its pharmacological activities

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

Fatal eosinophilic myocarditis in a healthy 17-year-old male with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2c)

A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV)

Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial

Ultrastructural evidence for direct renal infection with SARS-CoV-2

Coronaviruses: an overview of their replication and pathogenesis

COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Similarities in cutaneous histopathological patterns between COVID-19-positive and COVID-19 high-risk patients with skin dermatosis

Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin

CoV-2 protein interaction map reveals targets for drug repurposing

Natural product compounds in alpinia officinarum and ginger are potent SARS-CoV-2 papainlike protease inhibitors

Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019

Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway

Primary malignant cardiac tumors: a rare disease with an adventurous journey

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Xuebijing injection induces anti-inflammatory-like effects and downregulates the expression of TLR4 and NF-κB in lung injury caused by dichlorvos poisoning

COVID-19-related stroke

Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Dexamethasone in hospitalized patients with covid-19 -preliminary report

SARS-CoV-2 enterocolitis with persisting to excrete the virus for approximately two weeks after recovering from diarrhea: a case report

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb

A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)

Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19)

In Silico exploration of repurposing and optimizing traditional Chinese medicine rutin for possibly inhibiting SARS-CoV-2's main protease

Protective effect of baicalin on tert-butyl hydroperoxide-induced rat hepatotoxicity

Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type

Tanreqing Injection for community-acquired pneumonia: a systematic review of randomized evidence

Study on the active components in the adjuvant treatment of novel coronavirus pneumonia (COVID-19) with Jinhua Qinggan granules based on network pharmacology and molecular docking

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Anti-inflammatory plant flavonoids and cellular action mechanisms

Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients

SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum

Chemistry and biological activities of flavonoids: an overview

Effect of non-pharmaceutical interventions to contain COVID-19 in China

SARS-CoV-2 productively infects human gut enterocytes

Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-Frontiers in Pharmacology | www

Fisetin and rutin as 3C protease inhibitors of enterovirus A71

Traditional Chinese medicine contributes to the treatment of COVID-19 patients

Efficacy and safety of integrated traditional Chinese and western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

Anti-inflammatory effects of shenfu injection against acute lung injury through inhibiting HMGB1-NF-. Evid. Based Complement Alternat

Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes

Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients

Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient

Clinical observation on 63 cases of suspected cases of new coronavirus pneumonia treated by Chinese medicine Lianhua Qingwen

Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan

Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan

Tocilizumab treatment in COVID-19: a single center experience

Chinese herbal medicines in the prevention and treatment of chemotherapy-induced nausea and vomiting

Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical corona virus disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2

The effective rate of COVID-19 treated by integrated Traditional Chinese Medicine and western medicine is more than 92% in Beijing

Huang Luqi: Huashi Baidu recipe played an active role in the treatment of COVID-19 patients in Wuhan

The indications for the treatment of COVID-19 include jinhua Qinggan, Lianhua Qingwen and Xuebijing

Special instructions on standardizing the use and production of

Academician Zhang Boli: Qingfei Paidu decoction is an effective prescription for the treatment of COVID-19's mild illness

Notice on the promulgation of the national COVID-19 diagnostic and treatment guideline (provisional version 7) (Chinese)

Progress in screening of effective prescriptions of traditional Chinese medicine. Beijing, China: National Administration of Traditional Chinese Medicine

A variety of traditional Chinese medicine has been initially proved to have obvious curative effect, and the central guidance group requires timely summary

The History of Chinese epidemics

Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction

Takotsubo syndrome during SARS-CoV-2 pneumonia: a possible cardiovascular complication

A review on antibacterial, antiviral, and antifungal activity of curcumin

Diagnosis and treatment protocol for novel coronavirus pneumonia

Chemistry of phenolic compounds of licorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

Flavonoids: an overview

Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its antiinflammatory effect

Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2)

Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models

Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology

Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients Frontiers in Pharmacology | www

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition

Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection

Flavonoids as anti-inflammatory agents

Proteomic and metabolomic characterization of COVID-19 patient sera

Baicalin attenuates subarachnoid hemorrhagic brain injury by modulating blood-brain barrier disruption, inflammation, and oxidative damage in mice

XueBiJing injection versus placebo for critically ill patients with severe communityacquired pneumonia: a randomized controlled trial

Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections

Master equation analysis of mesoscopic localization in contagion dynamics on higher-order networks

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

Managing cutaneous immune-mediated diseases during the COVID-19 pandemic

Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection

Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

A deep learning algorithm using CT images to screen for corona virus disease (COVID-19)

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, A target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells

Sitespecific glycan analysis of the SARS-CoV-2 spike

Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus

Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

A new coronavirus associated with human respiratory disease in China

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Traditional Chinese medicine theory and clinical study on novel coronavirus pneumonia (NCP) infection

Evidence for gastrointestinal infection of SARS-CoV-2

Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated antiinflammatory and antioxidant effects

Mechanism of Qingfeipaidu decoction on COVID-19 based on network pharmacology

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Discovery of Anti-2019-nCoV agents from Chinese patent drugs via docking screening

Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants

Chemical composition and pharmacological mechanism of Qingfei Paidu decoction and Ma Xing Shi Gan decoction against coronavirus disease 2019 (COVID-19): in silico and experimental study

Clinical observation of Tan-Re-Qing injection on acute lung injury patients

Retrospective clinical analysis on treatment of novel coronavirus-infected pneumonia with traditional

Theoretical study of the anti-NCP molecular mechanism of traditional Chinese medicine lianhua-Qingwen formula (LQF)

Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells

Treatment effects of xuebijing injection in severe septic patients with disseminated intravascular coagulation. Evid. Based Complement Alternat

Study advances on glycyrrhizic acid, derivatives and their biological activities. Chin

Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

Syndrome in TCM and therapeutic effect of integrated medicine in patients with SARS

Evaluation of the adjuvant efficacy of natural herbal medicine on COVID-19: a retrospective matched case-control study

Potential interventions for novel coronavirus in China: a systematic review

Shen-fu injection attenuates postresuscitation lung injury in a porcine model of cardiac arrest

Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases

Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases

Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients

Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining

An artificial intelligence system reveals liquiritin inhibits SARS-CoV-2 by mimicking type I interferon

A novel coronavirus from patients with pneumonia in China

Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2020 Qiu, Huang, Liu, Huang, Li, Cui, Luo and Luo. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.